Carrier Screening for Spinal Muscular Atrophy in Pregnant Women
Author Information
Author(s): Su Yi-Ning, Hung Chia-Cheng, Lin Shin-Yu, Chen Fang-Yi, Chern Jimmy P. S., Tsai Chris, Chang Tai-Sheng, Yang Chih-Chao, Li Hung, Ho Hong-Nerng, Lee Chien-Nan
Primary Institution: National Taiwan University College of Medicine
Hypothesis
Routine carrier screening for spinal muscular atrophy (SMA) is feasible and beneficial in the general population.
Conclusion
The study found that SMA carrier screening can effectively identify carriers and provide genetic counseling to reduce the risk of having affected children.
Supporting Evidence
- 2,262 SMA carriers were identified among the 107,611 pregnant women screened.
- The carrier rate was approximately 1 in 48 (2.10%).
- The negative predictive value of the screening method was 99.87%.
- Prenatal diagnostic testing was performed in 43 women, with SMA diagnosed in 12 fetuses.
Takeaway
This study tested a lot of pregnant women to see if they carry a gene for a disease called spinal muscular atrophy, which can make babies very sick. They found many carriers and helped families understand their risks.
Methodology
A three-stage screening program was used to test pregnant women for SMA heterozygosity, followed by testing of partners if the mother was a carrier.
Limitations
The study may not identify all carriers, particularly those with two copies of SMN1 on one chromosome, and there is a risk of false negatives due to de novo mutations.
Participant Demographics
The study included 107,611 pregnant women from 25 counties in Taiwan, primarily Taiwanese, with a majority aged 20-39.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website